The tariff classification and country of origin of Doxorubicin Hydrochloride Liposome Injection in dosage form
Reasoning
The tariff classification and country of origin of Doxorubicin Hydrochloride Liposome Injection in dosage form
Cite this ruling
CBP Ruling N325855 (3004200060): The tariff classification and country of origin of Doxorubicin Hydrochloride Liposome Injection in dosage form
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300420
The tariff classification of ORLYNVAH™ (Sulopenem Etzadroxil and Probenecid) tablets in dosage form, from Italy
The tariff classification and country of origin of Doxycycline Capsules in dosage form
The tariff classification of Doxorubicin Hydrochloride Liposomal Injection in dosage form, from India
The tariff classification of Clindamycin Phosphate Topical Solution 1% in dosage form, from China
The tariff classification of Everolimus Tablets in dosage form, from India